• Skip to main content
  • Skip to primary sidebar
Yomi By Neocis logo with orange and black text
  • About Us
    • Company
    • Careers
    • Investors
  • The Robotic Practice
    • The Robotic Clinician
    • The Robotic Team
    • The Patient Experience
    • The Next Generation
  • Patients
    • Patient Experience
    • Doctor Finder
  • Education
    • Content Library
    • Yomi University
  • Products & Services
    • The Yomi Robot
    • YomiPlan
      • YomiPlan Complete
      • YomiPlan Dynamic
      • YomiPlan Go
    • Yomi Impact
  • News & Events
    • Events
    • Press
account icon
Request a demo
Neocis Inc. Closes $30M Equity Funding Round

MIAMI, July 15, 2019 (GLOBE NEWSWIRE) — Neocis Inc. today announced that it closed a $30 million equity financing round to support expanded commercialization and R&D efforts.

The Miami, FL based company said that the round was raised from existing investors, including Mithril Capital Management, and joined by new investor Norwest Venture Partners.

Dr. Robert Mittendorff, Partner at Norwest Venture Partners, will join the Board of Directors. “Norwest is excited to join the Neocis team. We believe there is a huge opportunity for robotics to transform healthcare. Neocis has demonstrated their ability to revolutionize dental surgery,” said Dr. Mittendorff.

“Having a group of investors and a Board of Directors so experienced in successfully commercializing robotic surgery will be critical as Neocis charges into the next phase of growth,” said Dr. Alon Mozes, CEO and Co-founder of Neocis. “This funding will secure our opportunity to expand sales and adoption of Yomi® and continue to innovate in the robotic surgery space.”

Neocis received FDA clearance for Yomi, its robot-assisted dental surgery system. Yomi is indicated for use to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides navigational guidance of the surgical instruments. Yomi provides surgical guidance through the use of haptic robotic technology, software, and multisensory feedback to help achieve the right position, angulation, and depth to place the implant exactly according to plan. Yomi enables a minimally invasive flapless approach, which has been proven to lead to faster surgery, faster recovery, and less pain for the patient.

 

About Neocis Inc.

Neocis®, a privately held company focused on improving health care through robotic assistance, manufactures and markets Yomi®, the first and only robot-assisted surgical platform for the dental industry. Headquartered in Miami, Fla., Neocis is venture-backed, including funding from Mithril Capital Management, Norwest Venture Partners, and robotic surgery industry pioneer Fred Moll. For more information visit www.Neocis.com.

Contact
info@neocis.com

[button link=”https://www.neocis.com/” color=”orange” newwindow=”yes”] Contact Neocis[/button]

Black Yomi By Neocis logo

Contact Us

2800 Biscayne Blvd. Suite 600 Miami, FL 33137
855-963-6247
support@neocis.com

Follow Us

Instagram logofacebook logoYouTube logoLinkedin logo

Quick Links

  • News & Events
  • Press
  • Careers
  • Request a Demo

Compliance

  • Indications for Use
  • Privacy Policy
Register now to be notified of upcoming events

Yomi® is the first and only FDA-cleared robot-assisted dental surgery system. Yomi is a computerized robotic navigational system intended to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides robotic navigational guidance of the surgical instruments. Yomi is intended for use in partially edentulous and fully edentulous adult patients who qualify for dental implants. More Info

© 2023 Neocis, Inc. NEOCIS and YOMI are registered trademarks of Neocis, Inc. All rights reserved. LB-0027-00 RM

X